The global thyroid cancer drugs market was valued at about $0.4 billion in 2018. North America was the largest region in the thyroid cancer drugs market in 2018. The thyroid cancer drugs market consists of sales of drugs that are used to treat thyroid cancer. The thyroid tissue is made up of follicular cells and parafollicular cells in which cancer develops. The types of thyroid cancer include follicular, papillary, medullary, anaplastic and thyroid lymphoma. Read More On The Global Thyroid Cancer Drugs Market Report @ https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report
The global thyroid cancer drugs market is expected to grow to $0.77 billion at a rate of around 17.7% through 2022. Increasing incidences of thyroid cancer, especially in women is driving the thyroid cancer drugs market. According to the American Cancer Society, women are three times more likely to develop thyroid cancer than men. Thyroid cancer is rising at a fast pace and it is estimated that 52,070 new cases of thyroid cancer will be found in the USA in 2019 and an estimated 2,170 deaths will occur because of the disease. The increase in thyroid cancer can be attributed to exposure to radiation, family history of goiter and some hereditary syndromes. Increasing use of targeted therapies for the treatment of thyroid cancer is acting as a restraint on the thyroid cancer drugs market.
Combination drugs are increasingly being used in the treatment of thyroid cancer as they are more effective and help prevent cancer progression. A combination drug includes two or more active pharmaceutical ingredients (APIs) combined in a single dosage form. These drugs reduce the development of drug resistance and prevent the growth of cancer cells.
Major players in the market are Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva parenteral medicines Inc., Jerome Stevens Pharmaceuticals Inc. Bristol-Myers Squibb Company (BMS) is an American pharmaceutical company, headquartered in New York City.
Request A Sample Of The Global Thyroid Cancer Drugs Market Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2601&type=smp
Points from Table of Contents:
2. Thyroid Cancer Drugs Market Characteristics
3. Thyroid Cancer Drugs Market Size And Growth
3.1. Global Thyroid Cancer Drugs Historic Market, 2014 – 2018, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Thyroid Cancer Drugs Forecast Market, 2018 – 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Thyroid Cancer Drugs Market Segmentation
4.1. Global Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Ipilimumab
Cabozantinib-S-Malate
Caprelsa (Vandetanib)
Doxorubicin Hydrochloride
Lenvatinib Mesylate
Nivolumab
Vandetanib
Others
4.2. Global Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Hospitals
Oncology Clinics
Research Organizations
Others
4.3. Global Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Radioiodine Ablation
Thyroid Stimulating Hormone (THS) Suppression
Chemotherapy
Targeted Multikinase Therapy
Others
5. Thyroid Cancer Drugs Market Regional And Country Analysis
5.1. Global Thyroid Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
5.2. Global Thyroid Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
6. Asia-Pacific Thyroid Cancer Drugs Market
6.1. Asia-Pacific Thyroid Cancer Drugs Market Overview
6.2. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
6.4. Asia-Pacific Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
7. China Thyroid Cancer Drugs Market
7.1. China Thyroid Cancer Drugs Market Overview
7.2. China Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion
7.3. China Thyroid Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion
7.4. China Thyroid Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion
8. India Thyroid Cancer Drugs Market
Order a Copy of Complete Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2601
About The Business Research Company.
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Media Contact
Company Name: The Business Research Company
Contact Person: Nitin
Email: Send Email
Phone: 08897263534
Address:1st Floor, Anshu Colors Building, Road Number 1 Park View Enclave, Jubilee Hills
City: Hyderabad 500033
State: Telengana
Country: India
Website: https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report